- Research
- Open access
- Published:
Neurons cytoskeletal architecture remodeling during the replication cycle of mouse coronavirus MHV-JHM: a morphological in vitro study
BMC Veterinary Research volume 20, Article number: 18 (2024)
Abstract
Nowadays, the population is still struggling with a post-COVID19 syndrome known as long COVID, including a broad spectrum of neurological problems. There is an urgent need for a better understanding and exploration of the mechanisms of coronavirus neurotropism. For this purpose, the neurotropic strain of mouse hepatitis virus (MHV-JHM) originating from the beta-coronavirus genus, the same as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been used. The role of the cytoskeleton during virus replication in neurons in vitro was determined to understand the mechanisms of MHV-JHM neuroinfection. We have described for the first time the changes of actin filaments during MHV-JHM infection. We also observed productive replication of MHV-JHM in neurons during 168 h p.i. and syncytial cytopathic effect. We discovered that the MHV-JHM strain modulated neuronal cytoskeleton during infection, which were manifested by: (i) condensation of actin filaments in the cortical layer of the cytoplasm, (ii) formation of microtubule cisternae structures containing viral antigen targeting viral replication site (iii) formation of tunneling nanotubes used by MHV-JHM for intercellular transport. Additionally, we demonstrated that the use of cytoskeletal inhibitors have reduced virus replication in neurons, especially noscapine and nocodazole, the microtubule shortening factors.
Introduction
One of the most tricky and unpredictable family of viruses, Coronavirideae, again has forced scientists to investigate crucial stages of viral replication [1]. During the replication cycle, the cytoskeleton plays an essential role and takes part in infection. In healthy, uninfected cells, these dynamic arrays and their associated motor proteins are responsible for the processes of proliferation, migration, differentiation, apoptosis, and intake and transport of cargo by the cell [2]. The cell’s scaffold comprises actin filaments (AFs), microtubules (MTs), and intermediate filaments (IFs). In the context of pathogen invasion, the most crucial role is played by the structures, MTs, as they are involved in the retrograde transport of viral particles, especially in the perinuclear zone, and AFs involved in the movement in the sub-membrane region, cell to cell transport, the entry and egress of virions [3]. Actin is the most abundant protein in eukaryotes. It forms a monomeric and spherical form called globular actin (G-actin), not found outside of myosin, and polymerized in the form of filaments (F-actin) [4]. Actin filaments are prominently accumulated in the sub-membranous region of the cell at its periphery (cell cortex AF). They are capable of forming shorter protrusions such as lamellipodia, membrane ruffle, bladders, and long ones such as filopodia, microvilli, or podosomes (looser bundles) and organized in parallel stress fibers (tightly packed bundles) [4, 5]. Actin filaments also form tubular F-actin-rich structures called TNTs (tunneling nanotubes). They connect the cytoplasm of neighboring and/or distant cells by mediating efficient intercellular communication. They are a kind of long cytoplasmic bridges with the ability to maintain homeostasis in the physiological processes of the cell. Unfortunately, viral particles and other pathogens use these formations at early or late stages of the life cycle, promoting viral spread. The usage of TNTs has been documented for a diverse group of viruses such as retroviruses, vaccinia virus, influenza A virus, human metapneumovirus, human herpes virus type I, and severe acute respiratory syndrome coronavirus 2 to promote viral entry, virus trafficking, and cell-to-cell spread. Especially neuron-neuron transfer of pathological Tau protein assemblies and prion-like proteins in neurodegenerative diseases [6,7,8,9].
Microtubules are ultrathin structures, unbranched cylinders made of alpha and beta-tubulin heterodimers that form the wall of protofilaments. In all eukaryotes, they are responsible for essential functions in the cell: segregation of chromosomes into daughter cells at cell division as a significant component of the mitotic spindle, for transport of vesicles and organelles within the cytoplasm, the highly asymmetric morphology of neurons and, together with MTs and IFs, for maintaining the dynamic spatial organization of the cytoplasm in the cell [4, 10,11,12]. Microtubules are distributed in the cytoplasm in the form of evenly spaced clusters. They form the axons and dendrites of neurocytes, the cytoplasmic protrusions of cells, e.g., fibroblasts, and the pseudopodia in protozoa. Nerve cells are particularly rich in microtubule bundles of the interphase cytoplasm. The structure of the cytoskeleton in neurons is extremely dynamic and is involved in axon transport and proliferation. Microtubules originate at sites called microtubule organization centers (MTOCs), including centrosomes. These structures are where the beginning of microtubule construction occurs. These centers are common organelles present in the perinuclear region, as well as Golgi Apart (GA). MTOCs are suspected of determining the proper location of GAs [4, 13]. Significant is the fact of interaction of microtubules with actin filaments which is possible due to the presence of MAP (microtubule associated proteins) molecules. The level of its phosphorylation influences the formation of branched structures of the cytoskeleton and 3D networks [14]. Moreover, the role of these connections and the MAP molecule is significant in viral infection. Many viruses have encoded their own MAPs to manipulate MT networks directly. These are human immunodeficiency virus type 1, Kaposi’s sarcoma-associated herpesvirus, Epstein-Barr virus, African swine fever virus, human herpes virus type 1, murine norovirus, murine coronavirus [15,16,17,18,19,20,21,22,23].
As early as 1970, it was discovered by electron microscopy that viral particles localize within cytoskeletal elements, and the effect on cross-linking architecture negatively affects viral replication [24]. Why is it important to know about the changes occurring in the cytoskeleton of cells? Especially in the context of cells of the nervous system, the dysfunction that occurs, the distortion of the architecture of the cytoskeleton leads to severe diseases, including neurodegenerative diseases such as Alzheimer, Parkinson, amyotrophic lateral sclerosis, tauopathies, Huntington’s disease, and Charcot Marie tooth disease [25,26,27]. The situation is more serious when changes in the cytoskeleton are induced by neurotropic viruses such as some coronaviruses, including the titular MHV-JHM and another well-known beta-coronavirus representative, SARS-CoV-2. Since 2020 cases of common neurological symptoms have been reported, including loss of smell and taste. Less common symptoms were seizures, stroke, and isolated cases of Guillain-Barre syndrome (GBS, acute demyelinating inflammation with coexisting axonal motor neuropathy) [28,29,30]. According to a recent study, long-term effects caused by SARS-CoV-2 infection include a significant decrease in the brain’s gray matter, changes in markers of damage to tissue connected to the primary olfactory cortex, and a significant reduction in overall brain volume in affected patients [31].
Diagnosed, with increasing frequency, long-term neurological complications due to SARS-CoV-2 infection oblige scientists to intensify research on the neurotropism and neuropathogenicity of coronaviruses. For this purpose, it seems necessary to create new in vitro models suitable for studying the molecular mechanisms of coronavirus neuropathogenicity. One of the coronaviruses that has already contributed to neurodegeneration research is mouse hepatitis virus, specifically the JHM strain (MHV-JHM) [32,33,34]. A broad spectrum of tissue tropism characterizes MHV strains, and single isolates cause respiratory, gastrointestinal, or CNS diseases [35]. The pulmonary (polytropic) strains of MHV: MHV-1, MHV-2, MHV-3, MHV-JHM (MHV-4), MHV-A59, and MHV-S, replicate initially in the respiratory and olfactory epithelium of the nasal cavity, then develop viremia and spread to the lungs, liver, bone marrow, brain, lymphoid tissue, and reproductive organs. Enterotropic strains, such as MHV-D, MHV-DVIM, MHV-Y, and MHV-RI, mainly infect the gut and can spread to the liver, lymphoid tissue, and spleen [36,37,38]. Neurotropic strains are the most studied due to their ability to cause acute encephalomyelitis with or without chronic axonal demyelination [34, 37, 39].
Considering various virus-cytoskeleton relationships presented above and the still unknown facts about the interaction of coronaviruses with cytoskeletal structures (especially in nerve cells), we have attempted to characterize the morphological characteristics of microfilaments and microtubules and to check the effect of selected chemicals affecting the disruption of cytoskeletal distribution on the efficiency of MHV-JHM infection in primary neuron cells derived from Balb/c(H-d2) mice (Fig. 1).
Methods
Primary neuronal cell culture
Balb/c(H-2d) mice were used to establish the primary culture of murine neurons using the method by Cymerys et al. [40]. Balb/c mice aged 6–8 weeks were purchased from Animal House of Mossakowski Medical Research Institute Polish Academy of Sciences (Warsaw) and were handled in accordance with the guidelines regarding the use and care of laboratory animals. All actions involving live animals were performed according to Polish Local Ethics Committee guidelines and conformed to applicable international standards. Pregnant female mice (16–19 days post mating) were sacrificed in general anesthesia induced with 2%-3% isoflurane in an induction chamber (MiniVac Complete Anesthesia Systems, Harvard Apparatus). After sedation mice were sacrificed by cervical dislocation. Fetuses were removed and decapitated for brain collection. Then isolated cerebral hemispheres from fetal’ brains were washed three times in cold HBSS solution (10× Hanks Buffer; Life Technologies Waltham MA, USA) and treated with 2,5% EDTA-free trypsin solution at 37°C in 5% CO2 for 15 min. Again, cells were washed three times in a warm HBSS solution after incubation and mechanically homogenized using a pipette. After suspending and counting, cells were plated onto poly-L-lysine or poly-D-lysine with laminin-coated coverslips for immunofluorescent staining and without for RT-qPCR replication analysis at a density of 5 × 104 neurons per well (3.6 cm2). Primary murine neurons were cultured in B-27 Neuron Plating Medium, consisting of the neurobasal medium, B-27 supplement, 200 mmol/l of glutamine, 10 mmol/l of glutamate, and penicillin/streptomycin antibiotics (1%) with 5% supplement of fetal bovine (5%) and 5% equine serum (5%) (Gibco Life Technologies, Waltham MA, USA). To avoid propagation of non-neural cells, cultures were maintained in a growth medium supplemented with 10 μM cytosine β-D-arabinofuranoside (after 3 days for 24 h) (Sigma-Aldrich, Darmstadt, Germany). Subsequently, the medium was removed and replaced with Neuron Feeding Medium (B-27 Neuron Plating Medium without glutamate; Life Technologies Waltham MA, USA). In such conditions, neurons were maintained for the next 8 days prior to analysis, infection, and treatments with inhibitors at 37°C with 5% CO2.
MHV-JHM maintenance
Mouse coronavirus (MHV, mouse hepatitis virus), neuropathological strain MHV-JHM [ATCC-VR-76513] was propagated and in mouse hepatocyte cell line [NCTC, ATCC-CCL-9.1]. The median tissue culture infectious dose (TCID50) was calculated using the Spearman-Kärber method [41]. Aliquots were stored at -70°C. All studies were conducted with the virus stock at the second passage level and titer of 107.8 TCID50/mL.
Primary cell culture infection
Primary neuronal cell cultures were infected with MHV-JHM strain (MOI = 1.25) for 60 min at 37°C. After incubation, the inoculum was removed, washed with PBS, and a fresh culture medium was added. Subsequently, infected cells were incubated for 2, 24, 48, 72, and 168 h at 37°C with 5% CO2.
Inhibitors and cell viability assay (XTT)
Mouse hepatocytes (ATCC-CCL-9.1) were cultured in a 96-well plate at 10,000 cells/well and incubated until fully confluent (24 h) at 37°C and a 5% CO2-enriched atmosphere. After full confluence was achieved, the culture fluid was aspirated, and a suspension of each serine protease and cytoskeletal inhibitors (Table 1) were added at a volume of 100 µl per well. The cultures were incubated for 24 h at 37°C and in an atmosphere enriched with 5% CO2. After incubation, 50 µl of XTT labeling mixture (Roche, The Cell Proliferation Kit II (XTT), Darmstadt, Germany) was added to each well. After a 4-h incubation (37°C, 5% CO2), a reading was taken at λ = 450 nm, subtracting the background measured at 600 nm. Individual assays were performed in 3 replicates, and the average absorbance value for each dilution was calculated, followed by the calculation of the percentage of viable cells compared to the positive control (assuming 100% viable cells for the absorbance value of the positive control).
Immunofluorescence staining and imaging
The immunofluorescence method was used to visualize cell structures and viral antigen. After incubation in desired infection time, primary neuronal cell cultures were washed twice in PBS (Sigma-Aldrich, Darmstadt, Germany), then fixed in 4% PFA (paraformaldehyde, ThermoFisher, Waltham MA, USA) for 30 min. After fixation, the cells were washed twice with PBS solution and further incubated with 0.5% Tween/PBS solution for 10 min at room temperature. Following, the cells were washed twice with PBS solution. The F-actin filaments were stained with 50 μL of TRITC-labelled phalloidin conjugate (500 µg/mL; Sigma-Aldrich) and incubated for 60 min in a wet chamber. Likewise, microtubules were stained for 60 min in a wet chamber with indirect immunofluorescence with Anti-β-Tubulin III antibody produced in rabbit (dilution 1:200, Sigma Aldrich, Darmstadt, Germany) and then visualized with a secondary antibody, Texas Red goat anti-rabbit IgG (dilution 1:2000, Sigma- Aldrich, Darmstadt, Germany) for 60 min. The presence of viral antigen was determined by indirect immunofluorescence, using SARS-CoV/SARS-CoV-2 Spike Protein S2 Monoclonal Antibody (1A9) (ThermoFisher, Waltham MA, USA, dilution 1:250) incubated overnight at 4°C. To visualize the viral antigen, Alexa Fluor 488 anti-mouse IgG was used for 60 min, RT. Additionally, cell nuclei were stained with Hoechst 33258 (ThermoFisher, Waltham MA, USA) for 2 min, RT. Afterward, coverslips were mounted on microscope slides using ProLong Gold Antifade Mounting Medium (ThermoFisher, Waltham MA, USA). Images were acquired in a confocal microscope (Fluoview FV10i, Olympus, Warsaw, Poland), saved in 24-bit.tiff format, and analyzed using FV10i software (Olympus), ImageJ2 (NIH Image, version 1.53q, Bethesda, MD, USA), and Adobe Photoshop CS6 software (Adobe Systems Incorporated, ver. 23.4.1, San Jose, CA, USA).
Cell treatment method with cytoskeleton-interfering inhibitor drugs
Primary neuron cells after maturation (day 14) and at proper confluence level (min 70%) were pretreated or post-treated with nocodazole 30μM/mL; cytochalasin D 10μM/mL; latrunculin A 10μM/mL; noscapine 75μM/mL; Taxol 10μM/mL, all dissolved in DMSO 1%. During the pre-treatment method, cells were incubated for 1 h with the desired drug at 37°C, 5% CO2 cells, then infected with MHV-JHM. After infection, the medium was replaced with a fresh culture medium. In the post-treatment method, cells were infected with MHV-JHM for 1 h at 37°C, 5% Co2. Then the cells were washed and left for incubation in a fresh medium containing the listed drugs. Primary neuronal cell cultures were further incubated for 2, 24, 48, 72, and 168 h. Cellular and supernatant fractions from appropriate periods were collected in RLT buffer (Qiagen, Germantown, MD, USA), stored at -20°C, and later used for RNA isolation and reverse transcription quantitative real-time PCR (RT-qPCR) analysis.
RNA isolation and reverse transcription quantitative real-time PCR (RT-qPCR)
Primer design and construction of standard for RT-qPCR
RNA from infected and control cells was isolated using RNeasy Mini Kit (Qiagen, Germantown, MD, USA) followed by cDNA 1st synthesis using random hexamer primer (RevertAid First Strand cDNA Synthesis Kit, ThermoFisher). Product spanning a particular region of the MHV genome (Gen Bank No. AC_000192.1) was amplified using MHV_L_full and MHV_R_full primers (Table 2), followed by electrophoresis and gel extraction. The extracted DNA fragment was used for reamplification and cloned in E. coli using pGEM®-T Easy Vector System (Promega), and recombinant plasmid pGEM-T/MHV_1 was achieved. RT-qPCR (in the total volume of 12 µl) with primers MHV_L_v2 (0.9 µM), MHV_R_v2 (0.9 µM), and probe (0.2 µM) (Table 2) was performed on cDNA from both infected and control cells, as well as on plasmid pGEM-T/MHV_1 construct using TaqMan™ Gene Expression Master Mix (ThermoFisher, Waltham MA, USA). The PCR was performed as follows 50°C – 2 min, 95°C- 10 min, 45 × (95°C – 15 s, 60°C – 1 min).
Measurement of MHV copies in samples using RT-qPCR
RNA was isolated from cells using RNeasy Mini Kit (Qiagen, Germantown, MD, USA), followed by RNA concentration measurement using Synergy H1 Microplate Reader (BioTeK) and cDNA 1st synthesis using random hexamer primers (RevertAid First Strand cDNA Synthesis Kit, ThermoFisher, Waltham MA, USA). The cDNA was diluted 40 × in water. In parallel control buffer (CON_buf) was prepared by mixing all necessary rea-gents for RT reaction except from RNA, dNTPs, and random hexamer primer: 14 µl of water, 4 µl of reaction buffer (5 × concentrated), 1 µl of RNA inhibitor and 1 µl of Reverse Transcriptase (RevertAid First Strand cDNA Synthesis Kit, ThermoFisher, Waltham MA, USA) were mixed and incubated 25°C – 5 min, 42°C - 60 min and 70°C – 5 min. The mixture was diluted 40 x, and CON_buf was achieved. The RT-qPCR was performed in 12 µl prepared as follows: 6 µl of 2 × TaqMan™ Gene Expression Master Mix (ThermoFisher, Waltham MA, USA), 2.16 µl of primers mix MHV_L_v2 and MHV_R_v2 (5 µM each), 1.2 µl of probe (2 µM) and 0.64 µl of water were mixed resulting in mixture volume of 10 µl. The mixture was added to the plate wells, and 2 µl of 40 × cDNA was added as matrices. To achieve a standard curve, pGEM-T/MHV_1 was diluted in CON_buf to achieve 1E8, 1E7, 1E6, 1E5, 1E4, 1E3, 1E2 and 33 copies per 2 µl and used as matrices for RT-qPCR. The PCR was performed as follows: 50°C – 2 min, 95°C - 10 min, 45 × (95°C – 15 s, 60° C – 1 min). Additionally, each plate contained a sample with cDNA from infected and control cells serving as positive and negative controls, respectively. Each reaction was performed in triplicate in MicroAmp™ Optical 96-Well Reaction Plate with Barcode using a thermocycler.
Real-time cell growth analise JuLiTMBr
To determine the cellular growth and morphology of primary neurons infected with MHV-JHM, the JuLITMBr Live Cell—system for bright-field analysis (NanoEnTek, Seoul, Korea 2015) was used. When cultured neurons reached about 80% confluency, cells were infected with MHV-JHM as previously described. Images were captured for 168 h with 30 min intervals. The results were obtained and analyzed using JuLITMBr PC software. Uninfected cells were used as a negative control. All images were captured at a × 40 magnification.
Statistical analysis
The results were statistically evaluated by one-way or two-way analysis of variation (ANOVA) using the Tukey multiple comparisons test or multiple unpaired t test using threshold p value with the Šídák-Bonerroni multiple comparisons correction method. All experiments were done at least in triplicate. These analyses were performed using GraphPad Prism™ version 9.4.0 (453) for macOS software (GraphPad Software Inc., San Diego, CA, USA). Statistical differences were interpreted as significant at p ≤ 0.05, highly significant at p ≤ 0.01, extremely significant at p ≤ 0.001, and insignificant at p > 0.05.
To analyze the colocalization of the fluorescence signal derived from TNTs and the viral antigen during the study, a minimum 100 confocal images were used. Images were analyzed using the Fiji BIOP JACoP plug-in. The parameters analyzed were two channels, green fluorescence corresponding to the viral antigen and red fluorescence for the F-actin. The quantitative interpretation of pixel correlation coefficients in the form of threshold parameters of Pearson’s correlation coefficient (PCC) and Manders’ correlation coefficient (M1 and M2) of global statistical analysis were considered for statistical analysis, considering pixel intensity distributions from fluorogram plots [42]. The degrees of correlation were indicated as perfect for values near ± 1; strong for values between ± 0.50 and ± 1; medium for values between ± 0.30 and ± 0.49, and low for values below + 0.29.
Results
MHV-JHM productively replicates in neurons
The number of copies of viral RNA were determined from the suspension of cells and media from each time post-infection (Fig. 2). In the positive control of neuron cells infected with MHV-JHM, the number of copies per µg RNA has been increasing logarithmically. At the start, after 2 h p.i., the virus copies were at 5.30 × 106 per µg RNA. Then, 24 h p.i. values increased to 1.03 × 108 copies/µg RNA when the complete replication cycle occurred. At 48 h p.i., values decreased by two logarithms (5.60 × 106) and gradually raised, reaching its peak – 6.48 × 109 at 168 h p.i. On the other hand, the morphological analysis done with JuLi™Br live imaging showed that neurons infected with MHV-JHM did not drastically change the confluence of the culture nor the appearance of cells (Fig. 3). During the 168 h of infection, the lower density of cell culture was observed, but the ability to form long protrusions or neuritis were present until the assay’s end. Therefore, there was no visible CPE, and cells did not undergo lysis. The confluence level had been raised until 96 h post infection (92.55%) and started to drop after 120 h p.i., reaching the final confluence of 64.06% at 168 h p.i. (Fig. 3, graph).
MHV-JHM controls the dynamic processes of the actin cytoskeleton
The effect of MHV-JHM on the cytoskeletal structure of primary cultured mouse neurons manifested in the form of changes in the distribution of filaments.
The first changes could be seen as early as 2 h p.i., where, compared to the control (Fig. 4) even arrangement of stress filaments (Fig. 5A, a’,a’’ yellow arrowheads), excessive condensation of actin in the submembranous region (Fig. 5A,a’’ green arrowhead; Fig. 6A, white asterisk) and its thinning in the zone close to the cell nucleus (Fig. 5A,a’’, white asterisk; Fig. 6A, yellow arrow) were noted. Also, the presence of penetrating/moving viral antigens in the long filopodia (Fig. 5A,a’’, white arrowhead) and the accumulation of virion antigen was captured in the perinuclear area, which is the site of target replication in the cytoplasm (Fig. 5A,a’, yellow box, green arrowhead).
The changes have worsened at 24 h p.i. When productive replication occurred, neurons formed many intercellular connections in the form of longitudinal actin filaments - tunnelling nanotubes, to transport viral particles to neighbour cells (Fig. 5B, b’ white arrowheads). It is possible to distinguish the formation of thin TNT bridges and long thicker ones (Fig. 5B, b’,b’’ white arrowheads). In the area marked by the yellow box, the progeny virions were present, moving across the bridge from one cell to another (Fig. 5B, b’’ green arrowheads). Peripheral stress fibres in the form of highly condensed structures were still visible (Fig. 5B, b’, b’’ yellow arrowheads), and a large amount of viral antigen localized in the perinuclear region (Fig. 5B, b’, yellow box, green arrowhead) with a much-diluted structure was still clearly visible.
Interesting morphological changes begin to occur on the second day after infection, where neurons clearly have lost their ability to form long protrusions (Fig. 5C, c’,c’’). Instead, shorter filopodia appeared (Fig. 5C, c’,c’’ white asterisk). Also, the structure of the stress fibres has again become highly polarized fibres in which the viral antigen was present (Fig. 5C, c’,c’’ green arrowheads and yellow arrowheads).
Complete rearrangement and loss of the proper structure of actin filaments and their local defragmentation occurred at 72 h p.i. (Fig. 5D, d’,d’’). The viral antigen was predominantly present in the perinuclear space where the actin structure has been polymerized (Fig. 5D, d’ yellow boxes green arrowheads).
Interestingly, 1 week after infection, the structure of the actin cytoskeleton has restored. (Fig. 5E, e’,e’’). Stress fibres (Fig. 5E, e’ yellow arrowheads), TNTs (Fig. 5E,e’’, yellow box, white arrowhead), and lamellipodia (Fig. 5E, e’ yellow box, white asterisk) could be distinguished. However, further examples of the cytopathic effect in the form of spiderweb-like structure (Fig. 5E, e’ yellow box) and cell syncytia (Fig. 5E, e’’ yellow arrowhead) appeared. The moving viral antigen have been still present in the actin protrusions (Fig. 5E, e’’ yellow box, green arrowhead). These actin structures were noticeable throughout the infection cycle but were best and most visible 1 week after infection. Such as numerous long actin protrusions and nanotubes in which the moving viral antigen was present (Fig. 7A,B,C; white arrow). A tunneling nanotubule connected two nerve cells transmitting virions between them (Fig. 7A a’’; white arrow). The quantification colocalization analysis of viral antigen and TNTs structure throughout the infection exhibited strong values (PCC = 0.73 ± 0.18; M1 = M2 = 0.93) (Fig. 8). Moreover, interesting spiderweb-like structures appeared with local highly polarized filaments and complete absence or depolarization (Figs. 6B and 7C; green boxes and yellow arrows).
Another interesting phenomenon was also observed. The formation of actin structures, highly polarized filaments forming a circle, was noted during infection at early and late time post infection (Fig. 6A,B). At 2 h p.i., the filaments were polarized in the perinuclear and submembrane area (Fig. 6A, white asterisk; yellow arrows) while at 168 h p.i., a significant condensation of polarized actin filaments were visible, forming a ring-like form in submembrane area (Fig. 6B, white asterisk, yellow arrow). In these structures, high number of viral particles were noted (Fig. 6A,B; green arrows).
MHV-JHM modulates microtubule structure and uses during transport
Microtubules are less involved in virus entry into the cell. In contrast, MTs in neurons facilitate viral transport along the neuron’s cell body and axonal terminals. This can be seen as early as 2 h p.i. as viral particles were moving ‘surfing’ inside MTs (Fig. 10Aa’’). In the box highlighted in yellow, attention was drawn to the accumulation of viral antigen in the perinuclear space and its presence in the neurite (Fig. 10Aa’’, yellow box, and green arrowheads). Also, viral antigen was visible in perinuclear area (Fig. 9Aa’’, yellow box, and green arrowheads).
Progressive accumulation of viral antigen was observed after the first day after infection. On images, it was manifested as yellow fluorescence present mainly in the soma region (Fig. 10Bb’, yellow box, green arrowhead). The dots of green fluorescence present in numerous dendrites likely represented progeny virions moving between neurons (Fig. 10Bb’, yellow box, green arrowheads). Early syncytium formation was also detected after 24 h p.i. (Fig. 10Bb’’, green and white arrowhead).
Compared to control (Fig. 9), microtubule architecture changes occurred after 48 h p.i. Microtubules radiated toward the forming syncytium (Fig. 10Cc’,c’’, yellow square, yellow arrowheads, white arrowhead) were noted. On the first image, a loss of dendrites, axons and a pronounced rounding of the neuron cell were seen (Fig. 10Cc’). In places, as captured in the second photo, a long protrusion is present in which the progeny virion was moving (Fig. 10Cc’’, yellow arrowhead, green arrowheads).
On the other hand, on the third day after infection, a restoration of the neurons’ ability to form protrusions was observed (Fig. 10Dd’,d’’, yellow arrowheads). However, compared to control (Fig. 9), the structure of MTs became depolymerized, facilitating the distribution of viral proteins (Fig. 10Dd’,d’’, yellow arrowheads). The second picture showed strong condensation of microtubules at the site of viral antigen and formation of bulges in dendrites - a possible site of release of progeny virus (Fig. 10D,d’’, yellow square, green arrowheads). Syncytia at 72 h p.i. were still present with a clear ring of viral antigen around fused cell nuclei (Fig. 10D,d’’, yellow squares, white arrowheads).
Interestingly similar to what was described for actin filaments, 1 week after infection, there was no loss of cellular protrusions, microtubule structure was similar to that present in control (Fig. 8) with well-defined polymerization (Fig. 10E,e’,’’, yellow arrowheads). Viral antigen was still present and expressed by bright fluorescence in each neuronal cell (Fig. 10E,e’ green arrowhead; e’’ green arrowhead, yellow box, green arrowhead), especially in the perinuclear space of the soma (Fig. 10E,e’ yellow box; e’’ green arrowhead). The cultured primary murine neurons were not degraded after 168 h p.i. MHV-JHM.
Effect of specific cytoskeleton inhibitors on MHV-JHM replication
Reverse transcriptase real-time PCR was applied to detect viral RNA in neuronal cells pre-treated and post-treated with actin and microtubule inhibitors to determine their effect on virus replication. The following substances were used: cytochalasin D 10uM/mL; latrunculin A 10uM/mL; paclitaxel 10uM/mL nocodazole 30uM/mL; noscapine 75uM/mL. Both treatment methods had a significant effect on replication. Starting from 2 h p.i. there were visibly higher levels of viral RNA copies than in control untreated cells (2.02 × 105) (Fig. 11A). After 24 h p.i., the viral copies decreased by at least 2 logarithms. The actin cytoskeleton inhibitors – cytochalasin D and latrunculin A had a similar effect on replication inhibition, but post-treatment method had better results. Compared to the positive control, viral RNA copies were at a level of 108, whereas after applying actin depolymerization agents, latrunculin A and cytochalasin D, the values had reached level of copies 107 in pre-treatment and 105 in post-treatment. Cytochalasin (pre-treatment 7.47 × 107; post-treatment 4.04 × 106), latrunculin A (pre-treatment 1.38 × 108; post-treatment 1.25 × 106). Approximate values were detected for microtubule destabilization agents (Fig. 11B). In 48 h p.i. there was no spectacular effect both from actin and microtubular inhibitors. Overall positive control viral RNA copies were at a relatively high level of 108 (1.13 × 108) logarithm. After incubation best results were obtained for latrunculin A post-treatment (2.45 × 106) (Fig. 11C). On the contrary, 72 h p.i. with extreme significance, microtubule shortening noscapine, post-treatment (7.6 × 103), decreased viral replication by 4 logarithms compared to untreated control (1.2 × 107). Similar results were obtained with post-treatment actin depolymerizing cytochalasin D (6.1 × 104). Other pair of actin and microtubule inhibitors, latrunculin A, and paclitaxel, arrested viral replication on levels of 8.0 × 104 pre-treatment, 1.6 × 105, and 1.7 × 105 pre-treatment, 5.9 × 106 post-treatment as followed (Fig. 11D). Overall, the viral replication levels drop happened at 168 h p.i. where levels decreased by 6 logarithms after usage of post-treatment (6.3 × 104) and pre-treatment (2.3 × 104) incubation with nocodazole. Control untreated cells, infected with MHV-JHM (168 h p.i.), have reached value of 1010. Other microtubule inhibitors - noscapine and post-treatment actin depolymerization substations cytochalasin D, and latrunculin A have blocked replication by 2/3 logarithm (Fig. 11E).
Discussion
Several works have examined and confirmed the cell’s cytoskeleton’s significant role in the virus entry into the cell and in the further stage of the replication cycle, culminating in the assembly and release of progeny virions. Much is already discovered in the context of coronaviruses, but unknown areas still leave doubts. We have delved into this topic, not least because of the increasingly reported cases of long-Covid in the CNS [43,44,45]. As is well known, MHV, especially neurotropic strains, e.g., JHM, A549, are well suited as models for SARS-CoV-2 [34]. Moreover, morphological, and molecular analysis of the effect of MHV-JHM infection on the cytoskeleton of primary neurons adds to the knowledge of beta-coronaviruses. Our study confirmed that MHV-JHM in 1 week infection period does not destroy neuronal cells and manipulate the cytoskeleton from entry until viral shedding. What is more important MHV-JHM uses tunnelling nanotubules as a cell-to-cell transport route avoiding immune response and direct receptor binding.
During neuroinfection, the cytoskeleton plays a very significant role. In our study, we presented a morphological and quantitative analysis verifying the level of viral replication after treating cells with substances that affect the distribution of actin filaments and microtubules. There is little information available on the utilization of the neural cell cytoskeleton by MHV-JHM. The available literature has focused more on the role of microtubules during intracellular transport than actin filaments. Microtubules have been shown to play an important role in intraneuronal transport in primary culture cells of rat hippocampal neurons and OBL-21 cells (olfactory bulb cultures of CD.1 mouse) [46]. Moreover, the team of Pasick et al. 1994 and Kalicharran and Dales, 1995 proved that there is a special interaction between Tau protein and MHV-JHM nucleocapsid protein [23, 46]. The amino acid complementarity of the two proteins overlapped at 44% similarity and 22% identity in structure. This homology probably influences such high neuropathogenicity and tropism of the virus through the interaction of MTs with MHV-JHM N protein. Some α-coronaviruses like TGEV (transmissible gastroenteritis coronavirus), HCoV-NL63 (human coronavirus NL63), and HCoV-229E (human coronavirus 229E) were proven to interact with their S and M proteins directly or indirectly with tubulin [47]. In our study, we confirmed the dominant role of microtubules during MHV-JHM infection. We already observed at 24 h p.i. moving viral particles between neurons in long axonal protuberances and neurites (Fig. 10B, green arrowheads and yellow boxes). On the other hand, at 2 h p.i. (Fig. 10A, a’’ yellow box) and 72 h p.i. (Fig. 10D, d’’ yellow and green arrowheads), MHV-JHM disrupted microtubules’ architecture, leading to their depolymerization, cell degradation, and syncytia formation (Fig. 10C, D yellow arrowheads). However, some cells were still able to transport progeny virions (Fig. 10C, D green arrowheads). Neurites did not disappear, and virions accumulated in characteristic cisternae (Fig. 10D, purple arrowheads). At 168 h p.i., the viral antigen was still present in large amounts and colocalized with the structures of the microtubule, which were intact, and the cells were not degraded (Fig. 10E). Similar results were obtained by Pasick et al. where viral antigen were present in large amounts after 48 h p.i. Virions located in a linear position were moving along axons and have formed microtubules into cisternae structures [46]. On the other hand, a study by Biswas and Sarma [48], using demyelinating strains of MHV - RSA59 and non-demyelinating RSMHV2 in the infection of Neuro2a cells, showed that viral transport took place in axonal terminals as early as 4h 15 min p.i. in the case of RSA59 and RSMHV2 in general, up to 36 h p.i. when the cells lysed. Syncytia were present as early as 9 h p.i. in Neuro2a cells upon RSA59 infection [48]. We also detected syncytium formation by MHV-JHM after 24 h p.i. as a cytopathic effect in primary murine neurons (Fig. 10B, b’’, white arrowhead), contrary to the previous finding by Bender et al. [49]. Thus, it proves that direct cell-to-cell spread in neurons may be the top way of virion spread because of its efficiency and no engagement with cell-membrane-specific receptors [50, 51]. Also, after a week of infection, we observed the renovation of the cytoskeletal structure of neurons and an increase in proliferation. Generally, infection with MHV may lead to Tau phosphorylation by glycogen synthase kinase-3β-dependent mechanism, which disrupts MT stabilizing ability causing brain damage but not neurons death [52, 53]. The results were observed by analysis of confocal microscopy images were confirmed by RT-qPCR. After pre-, and post-treating with microtubules depolymerizing agent – nocodazole, a stabilizing agent – noscapine, and paclitaxel, we have observed successful limitation in MHV-JHM replication (Fig. 11). This indicates that disrupted MTs distribution, mostly in late hours post infection (a significant number of RNA copies decreased at 72 h p.i.) had a highly statistical effect on the virus’s ability to replicate in primary murine neurons. The best results were obtained by noscapine 72 h p.i. post-infection treatment by three logarithms drops and nocodazole pre-treatment by six logarithms drop (Fig. 11). In other viruses, the replication of sindbis virus, vesicular stomatitis virus, and human herpes virus type I, was quantified by the titre (plaque forming units/ml; pfu/ml) produced in cells treated with three anti-microtubule drugs (colchicine, noscapine, or paclitaxel) and none of these drugs affected the replication [54]. In the case of MHV-A59 and MHV-2 treatment with colchicine, vinblastine did not affect fusogenic properties and thus replication in 36 h p.i. in Neuro2a cells and fibroblasts [48, 55].
To our knowledge, no publications considered changes in actin filament during MHV-JHM infection in neurons. We have observed dynamic rearrangement of F-actin which led to facilitated MHV-JHM entry into the soma (Fig. 5). It is well known that microfilaments participate in virion surfing after the virus binds to a target cell [54]. In our study, as early as 2 h post infection, the filament condensation in the form of submembranous rings were seen (Fig. 5A,a’’ green arrowhead; Fig. 6). These structures, which can be sites of viral entry, were also present after IPEC-J2 cells infection with PEDV (Porcine epidemic diarrhoea virus) and TGEV (Transmissible gastroenteritis coronavirus) [56]. The first changes appeared 2 h p.i., where excessive condensation of actin in the submembranous region and its thinning in the zone close to the cell nucleus (Fig. 9A, green arrows) were noted. We also captured the penetrating/moving viral antigens in the long filopodial protuberance (Fig. 9A, white arrowhead) and the accumulation of virion antigen in the perinuclear area. The changes worsened at 24 h p.i. when productive replication occurred. Neurons formed numerous intercellular connections in the form of longitudinal actin filaments, probably forming tunnelling nanotubes for transporting viral particles. The use of TNTs and their important involvement in intercellular transport during SARS-CoV-2 infection has recently been discovered. The enhanced ability to form TNTs and the movement of viral antigen within the bridges were investigated on a coculture model of African green monkey kidney Vero E6 cell and human neuroblastoma (SH-SY5Y) cells [57]. In our study conducted on primary murine neurons, numerous TNT structures were seen and the movement of MHV-JHM antigen within TNTs throughout the infection period were noted. Interestingly, the largest number of this actin structures appeared after 168 h p.i. which may be an important sign especially in the treatment or research for the pathology of long-COVID and the changes that coronaviruses cause in the central nervous system.
Peripheral stress fibres in the form of highly condensed fibres were visible, and a large amount of viral antigen localized in the perinuclear region (Fig. 9B, white arrowheads) with a much-diluted structure was still clearly visible. Like in microtubule structure, proper actin filaments dynamics were restored after 168 h p.i. (Fig. 9E). During later hours post infection, characteristic juxtanuclear rings were observed. Again, in PEDV and TGEV infected IPEC-J2 cells, juxtanuclear rings support viral genome replication and protein synthesis [56]. Actin filaments also promote viral egress by thickening and restoring stress fibres structures, as we noted. Such phenomenon occurred during IBV (Infectious Bronchitis Virus) and SARS-CoV infection and proved essential during virus budding and assembly of viral particles [31, 58, 59]. To confirm the role of the actin cytoskeleton in MHV-JHM infection, we have used cytochalasin D and Latrunculin A treatment (Fig. 11). These two actin polymerization inhibitors did not influence the entry of the virus, thus the replication ability of MHV-JHM after 2 h p.i., but in later stages of replication, the inhibitory effect was visible by three logarithms decreased after 168 h p.i. In a study by Yeung 2021, BafA1 and cytochalasin D, which impair endosomal acidification and endosomal-lysosomal system, respectively, were proven to inhibit the infection of the SARS-CoV-2 virus [60].
In conclusion, here, we showed that neuronal actin cytoskeleton is likely used during MHV-JHM infection, which we confirmed by morphological analysis. Its role is not essential in the process of viral penetration but crucial in cell-to-cell transport of progeny virions. This type of viral transport permits infected cells to hide from immune system response and allows more effective viral spreading. Our studies show that the primary role in the intracellular transport of MHV-JHM virions to the site of replication and then between cells is played by microtubules. This finding was confirmed after using noscapine and nocodazole inhibitors, which effectively reduced MHV-JHM replication in neurons.
Availability of data and materials
The datasets used and/or analysed during the current study are included in this publication.
References
Zhang XY, Huang HJ, Zhuang DL, Nasser MI, Yang MH, Zhu P, et al. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Infect Dis Poverty. 2020;9(1):99.
Kubitschke H, Schnauss J, Nnetu KD, Warmt E, Stange R, Kaes J. Actin and microtubule networks contribute differently to cell response for small and large strains. New J Phys. 2017;19(9):093003.
Walsh D, Naghavi MH. Exploitation of cytoskeletal networks during early viral infection. Trends Microbiol. 2019;27(1):39–50.
Kłyszejko-Stefanowicz L. Cytobiochemia – biochemia niektórych struktur komórkowych. 3rd ed. Warsaw: PWN SA; 2015. p. 58–62.
Wen Z, Zhang Y, Lin Z, Shi K, Jiu Y. Cytoskeleton—a crucial key in host cell for coronavirus infection. Yao X, editor. J Mol Cell Biol. 2021;12(12):968–79.
Tiwari V, Koganti R, Russell G, Sharma A, Shukla D. Role of tunneling nanotubes in viral infection, neurodegenerative disease, and cancer. Front Immunol. 2021;12:680891.
Tardivel M, Bégard S, Bousset L, Dujardin S, Coens A, Melki R, et al. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathol Commun. 2016;4(1):117.
Abounit S, Wu JW, Duff K, Victoria GS, Zurzolo C. Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion. 2016;10(5):344–51.
Panasiuk M, Rychłowski M, Derewońko N, Bieńkowska-Szewczyk K. Tunneling nanotubes as a novel route of cell-to-cell spread of herpesviruses. Sandri-Goldin RM, editor. J Virol. 2018;92(10):e00090–18.
Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol. 1997;13(1):83–117.
Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu Rev Cell Dev Biol. 2000;16(1):89–111.
Döhner K, Sodeik B. The role of the cytoskeleton during viral infection. In: Marsh M, editor. Membrane trafficking in viral replication. Berlin/Heidelberg: Springer-Verlag; 2005. p. 67–108. (Current Topics in Microbiology and Immunology; vol. 285). Available from: http://link.springer.com/10.1007/3-540-26764-6_3. Cited 2023 Feb 7.
Sanchez AD, Feldman JL. Microtubule-organizing centers: from the centrosome to non-centrosomal sites. Curr Opin Cell Biol. 2017;44:93–101.
Mohan R, John A. Microtubule-associated proteins as direct crosslinkers of actin filaments and microtubules: ROLE OF MAPs IN THE ACTIN-MICROTUBULE NETWORK. IUBMB Life. 2015;67(6):395–403.
Elliott G, O’Hare P. Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules. J Virol. 1998;72(8):6448–55.
Diefenbach RJ, Davis A, Miranda-Saksena M, Fernandez MA, Kelly BJ, Jones CA, et al. The basic domain of herpes simplex virus 1 pUS9 recruits kinesin-1 to facilitate egress from neurons. Sandri-Goldin RM, editor. J Virol. 2016;90(4):2102–11.
Sathish N, Zhu FX, Yuan Y. Kaposi’s sarcoma-associated herpesvirus ORF45 interacts with kinesin-2 transporting viral capsid-tegument complexes along microtubules. Farzan M, editor. PLoS Pathog. 2009;5(3):e1000332.
Glon D, Vilmen G, Perdiz D, Hernandez E, Beauclair G, Quignon F, et al. Essential role of hyperacetylated microtubules in innate immunity escape orchestrated by the EBV-encoded BHRF1 protein. Lin Z, editor. PLoS Pathog. 2022;18(3):e1010371.
Alonso C, Miskin J, Hernáez B, Fernandez-Zapatero P, Soto L, Cantó C, et al. African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein. J Virol. 2001;75(20):9819–27.
Santos da Silva E, Shanmugapriya S, Malikov V, Gu F, Delaney MK, Naghavi MH. HIV ‐1 capsids mimic a microtubule regulator to coordinate early stages of infection. EMBO J. 2020;39(20). Available from: https://onlinelibrary.wiley.com/doi/10.15252/embj.2020104870. Cited 2023 Feb 7.
de Mareuil J, Carre M, Barbier P, Campbell GR, Lancelot S, Opi S, et al. HIV-1 Tat protein enhances microtubule polymerization. Retrovirology. 2005;2(1):5.
Cotton BT, Hyde JL, Sarvestani ST, Sosnovtsev SV, Green KY, White PA, et al. The norovirus NS3 protein is a dynamic lipid- and microtubule-associated protein involved in viral RNA replication. Dermody TS, editor. J Virol. 2017;91(3):e02138–16.
Kalicharran K, Dales S. Involvement of microtubules and the microtubule-associated protein TAU in trafficking of JHM virus and components within neurons. In: Talbot PJ, Levy GA, editors. Corona- and related viruses. Boston: Springer, US; 1995. p. 57–61. (Advances in Experimental Medicine and Biology; vol. 380). Available from: http://link.springer.com/10.1007/978-1-4615-1899-0_8. Cited 2023 Feb 7.
Ploubidou A, Way M. Viral transport and the cytoskeleton. Curr Opin Cell Biol. 2001;13(1):97–105.
McMurray CT. Neurodegeneration: diseases of the cytoskeleton? Cell Death Differ. 2000;7(10):861–5.
Cairns NJ, Lee VMY, Trojanowski JQ. The cytoskeleton in neurodegenerative diseases: cytoskeletal proteins in neurodegenerative diseases. J Pathol. 2004;204(4):438–49.
Eira J, Silva CS, Sousa MM, Liz MA. The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders. Prog Neurobiol. 2016;141:61–82.
Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14–22.
Lingor P, Demleitner AF, Wolff AW, Feneberg E. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t. J Neural Transm. 2022;129(9):1155–67.
Hosking MP, Lane TE. The pathogenesis of murine coronavirus infection of the central nervous system. Crit Rev Immunol. 2010;30(2):119–30.
Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697–707.
Khateb M, Bosak N, Muqary M. Coronaviruses and central nervous system manifestations. Front Neurol. 2020;11:715.
Morgello S. Coronaviruses and the central nervous system. J Neurovirol. 2020;26(4):459–73.
Körner R, Majjouti M, Alcazar M, Mahabir E. Of mice and men: the coronavirus MHV and mouse models as a translational approach to understand SARS-CoV-2. Viruses. 2020;12(8):880.
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: Maier HJ, Bickerton E, Britton P, editors. Coronaviruses. New York: Springer New York; 2015. p. 1–23. (Methods in Molecular Biology; vol. 1282). Available from: http://link.springer.com/10.1007/978-1-4939-2438-7_1. Cited 2023 Feb 7.
Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 2005;69(4):635–64.
Matthews A, Weiss S, Paterson Y. Murine hepatitis virus–a model for virus-induced CNS demyelination. J Neurovirol. 2002;8(2):76–85.
Weiss SR, Leibowitz JL. Coronavirus pathogenesis. In: Advances in virus research. Elsevier; 2011. p. 85–164. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780123858856000092. Cited 2023 Feb 7.
Cowley TJ, Long SY, Weiss SR. The murine coronavirus nucleocapsid gene is a determinant of virulence. J Virol. 2010;84(4):1752–63.
Cymerys J, Dzieciątkowski T, Słońska A, Bierła J, Tucholska A, Chmielewska A, et al. Equine herpesvirus type 1 (EHV-1) replication in primary murine neurons culture. Pol J Vet Sci. 2010;13(4). Available from: http://journals.pan.pl/dlibra/publication/121082/edition/105483/content. Cited 2023 Feb 7.
Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn-Schmiedebergs. Arch Für Exp Pathol Pharmakol. 1931;162(4):480–3.
Barlow AL, MacLeod A, Noppen S, Sanderson J, Guérin CJ. Colocalization analysis in fluorescence micrographs: verification of a more accurate calculation of Pearson’s correlation coefficient. Microsc Microanal. 2010;16(6):710–24.
Naghavi MH, Walsh D. Microtubule regulation and function during virus infection. Glaunsinger BA, editor. J Virol. 2017;91(16):e00538–17.
Colombo J, Weintraub MI, Munoz R, Verma A, Ahmad G, Kaczmarski K, et al. Long COVID and the autonomic nervous system: the journey from dysautonomia to therapeutic neuro-modulation through the retrospective analysis of 152 patients. NeuroSci. 2022;3(2):300–10.
Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267–9.
Pasick J, Dales S. MHV-JHM infections of rodent neuronal cells: replication and trafficking of structural proteins and progeny virions. In: Laude H, Vautherot JF, editors. Coronaviruses. Boston: Springer US; 1994. p. 319–25. (Advances in Experimental Medicine and Biology; vol. 342). Available from: http://link.springer.com/10.1007/978-1-4615-2996-5_49. Cited 2023 Feb 7.
Rüdiger AT, Mayrhofer P, Ma-Lauer Y, Pohlentz G, Müthing J, von Brunn A, et al. Tubulins interact with porcine and human S proteins of the genus Alphacoronavirus and support successful assembly and release of infectious viral particles. Virology. 2016;497:185–97.
Biswas K, Das Sarma J. Effect of microtubule disruption on neuronal spread and replication of demyelinating and nondemyelinating strains of mouse hepatitis virus in vitro. Perlman S, editor. J Virol. 2014;88(5):3043–7.
Bender SJ, Weiss SR. Pathogenesis of murine coronavirus in the central nervous system. J Neuroimmune Pharmacol. 2010;5(3):336–54.
Sattentau QJ. The direct passage of animal viruses between cells. Curr Opin Virol. 2011;1(5):396–402.
Sattentau Q. Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol. 2008;6(11):815–26.
Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C, et al. Role of tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci. 2019;11:204.
Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane TE, et al. Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol. 2011;178(6):2811–22.
Matthews JD, Morgan R, Sleigher C, Frey TK. Do viruses require the cytoskeleton? Virol J. 2013;10(1):121.
Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 1984;34(5):597–597.
Zhao S, Gao J, Zhu L, Yang Q. Transmissible gastroenteritis virus and porcine epidemic diarrhoea virus infection induces dramatic changes in the tight junctions and microfilaments of polarized IPEC-J2 cells. Virus Res. 2014;192:34–45.
Pepe A, Pietropaoli S, Vos M, Barba-Spaeth G, Zurzolo C. Tunneling nanotubes provide a route for SARS-CoV-2 spreading. Sci Adv. 2022;8(29):eabo0171.
Ng ML, Lee JWM, Leong MLN, Ling AE, Tan HC, Ooi EE. Topographic changes in SARS coronavirus–infected cells at late stages of infection. Emerg Infect Dis. 2004;10(11):1907–14.
Gov NS, Gopinathan A. Dynamics of membranes driven by actin polymerization. Biophys J. 2006;90(2):454–69.
Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai JP, et al. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell. 2021;184(8):2212–2228.e12.
Acknowledgements
Not applicable.
Funding
This research was funded by grant number 2021/41/N/NZ6/04383 (to MB) from National Science Centre in Cracow, Poland. The publication was financed by Science development fund of the Warsaw University of Life Sciences - SGGW.
Author information
Authors and Affiliations
Contributions
Conceptualization, M.B., and J.C.; methodology, M.B., J.C., P.B., M.C.; software, M.B.,P.B.; validation, P.B., J.C., M.B.; formal analysis, M.B, J.C., P.B.; investigation, M.B., J.C., P.B.; resources, M.C., M.W.B; data curation, M.B., P.B.; writing—original draft preparation, M.B.; writing—review and editing, M.B., P.B., J.C., M.C., B.T.; visualization, M.B., M.C.; supervision, J.C., M.W.B., project administration, M.B., J.C.; funding acquisition, M.B.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
This type of research does not require permission from the ethics committee. Relevant documents have been included. The Ethics review board II Local Committee for Ethics in Animal Research of Warsaw University of Life Sciences - SGGW considers that this type of project does not fall under the legislation for the protection of animals used for scientific purposes, national decree-law (Dz. U. 2015 poz. 266 and 2010-63-EU directive). Moreover, the research team members have training issued by Polish Laboratory Animal Science Association (PolLASA) in animal handling, planning experiments, performing procedures, and killing animals.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Bartak, M., Bąska, P., Chodkowski, M. et al. Neurons cytoskeletal architecture remodeling during the replication cycle of mouse coronavirus MHV-JHM: a morphological in vitro study. BMC Vet Res 20, 18 (2024). https://doi.org/10.1186/s12917-023-03813-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12917-023-03813-y